| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.986 | 0.001 | 0.986 | Hypoxia-inducible factor 1 alpha inhibitor | 0.864 0.003 DBMET02912 0.961 0.002 DBMET02914 0.958 0.002 DBMET02915 0.926 0.002 DBMET00476 0.886 0.002 DBMET02913 0.955 0.002 DBMET00353 | ||
| 0.985 | 0.004 | 0.986 | Antiinflammatory | 0.979 0.004 DBMET02912 0.982 0.004 DBMET02914 0.981 0.004 DBMET02915 0.984 0.004 DBMET00476 0.98 0.004 DBMET02913 0.986 0.003 DBMET00353 | DBMET00353 | |
| 0.976 | 0.001 | 0.976 | Antipruritic | 0.885 0.002 DBMET02912 0.96 0.001 DBMET02914 0.926 0.002 DBMET02915 0.921 0.002 DBMET00476 0.882 0.002 DBMET02913 0.901 0.002 DBMET00353 | ||
| 0.965 | 0.004 | 0.965 | Toll-Like receptor agonist | 0.943 0.004 DBMET02912 0.964 0.004 DBMET02914 0.961 0.004 DBMET02915 0.963 0.004 DBMET00476 0.824 0.005 DBMET02913 0.846 0.005 DBMET00353 | ||
| 0.964 | 0.004 | 0.964 | Toll-Like receptor 7 agonist | 0.943 0.004 DBMET02912 0.963 0.004 DBMET02914 0.96 0.004 DBMET02915 0.963 0.004 DBMET00476 0.82 0.005 DBMET02913 0.849 0.005 DBMET00353 | ||
| 0.958 | 0.003 | 0.958 | Transcription factor NF kappa B inhibitor | 0.932 0.004 DBMET02912 0.934 0.004 DBMET02914 0.935 0.004 DBMET02915 0.95 0.003 DBMET00476 0.94 0.004 DBMET02913 0.935 0.004 DBMET00353 | ||
| 0.909 | 0.002 | 0.909 | Androgen antagonist | 0.764 0.002 DBMET02912 0.841 0.002 DBMET02914 0.764 0.002 DBMET02915 0.655 0.003 DBMET00476 0.757 0.002 DBMET02913 0.81 0.002 DBMET00353 | ||
| 0.903 | 0.001 | 0.903 | Interferon gamma antagonist | 0.668 0.001 DBMET02912 0.722 0.001 DBMET02914 0.717 0.001 DBMET02915 0.712 0.001 DBMET00476 0.652 0.001 DBMET02913 0.618 0.002 DBMET00353 | ||
| 0.861 | 0 | 0.861 | Arachidonic acid antagonist | 0.527 0 DBMET02912 0.639 0 DBMET02914 0.554 0 DBMET02915 0.691 0 DBMET00476 0.577 0 DBMET02913 0.52 0 DBMET00353 | ||
| 0.825 | 0 | 0.825 | Glucocorticoid agonist | 0.781 0.001 DBMET02912 0.802 0.001 DBMET02914 0.798 0.001 DBMET02915 0.803 0.001 DBMET00476 0.707 0.001 DBMET02913 0.781 0.001 DBMET00353 | ||
| 0.811 | 0.003 | 0.811 | Breast cancer-resistant protein inhibitor | 0.561 0.004 DBMET02912 0.799 0.003 DBMET02914 0.721 0.004 DBMET02915 0.801 0.003 DBMET00476 0.09 0.065 DBMET02913 0.113 0.044 DBMET00353 | ||
| 0.776 | 0.004 | 0.776 | Immunosuppressant | 0.762 0.004 DBMET02912 0.769 0.004 DBMET02914 0.758 0.004 DBMET02915 0.771 0.004 DBMET00476 0.74 0.004 DBMET02913 0.76 0.004 DBMET00353 | ||
| 0.741 | 0 | 0.741 | Corticosteroid-like | 0.526 0 DBMET02912 0.661 0 DBMET02914 0.613 0 DBMET02915 0.662 0 DBMET00476 0.267 0.001 DBMET02913 0.389 0 DBMET00353 | ||
| 0.692 | 0.002 | 0.692 | Interleukin 5 antagonist | 0.512 0.003 DBMET02912 0.674 0.002 DBMET02914 0.654 0.002 DBMET02915 0.674 0.002 DBMET00476 0.266 0.004 DBMET02913 0.306 0.004 DBMET00353 | ||
| 0.675 | 0 | 0.675 | Lipocortins synthesis agonist | 0.442 0 DBMET02912 0.616 0 DBMET02914 0.547 0 DBMET02915 0.622 0 DBMET00476 0.249 0.001 DBMET02913 0.337 0 DBMET00353 | ||
| 0.631 | 0.043 | 0.764 | Apoptosis agonist | 0.699 0.031 DBMET02912 0.596 0.05 DBMET02914 0.607 0.048 DBMET02915 0.601 0.049 DBMET00476 0.763 0.021 DBMET02913 0.764 0.021 DBMET00353 | DBMET00353 | |
| 0.568 | 0.003 | 0.693 | Lipocortins synthesis antagonist | 0.59 0.002 DBMET02912 0.572 0.002 DBMET02914 0.565 0.003 DBMET02915 0.541 0.003 DBMET00476 0.647 0.002 DBMET02913 0.693 0.001 DBMET00353 | DBMET00353 | |
| 0.543 | 0.003 | 0.543 | Interleukin 2 antagonist | 0.275 0.005 DBMET02912 0.538 0.003 DBMET02914 0.394 0.004 DBMET02915 0.498 0.003 DBMET00476 | ||
| 0.536 | 0.013 | 0.602 | Nitric oxide antagonist | 0.527 0.014 DBMET02912 0.495 0.016 DBMET02914 0.521 0.014 DBMET02915 0.575 0.011 DBMET00476 0.565 0.012 DBMET02913 0.602 0.01 DBMET00353 | DBMET00353 | |
| 0.524 | 0.002 | 0.675 | Glucocorticoid antagonist | 0.423 0.002 DBMET02912 0.421 0.002 DBMET02914 0.43 0.002 DBMET02915 0.432 0.002 DBMET00476 0.441 0.002 DBMET02913 0.675 0.001 DBMET00353 | DBMET00353 | |
| 0.522 | 0.018 | 0.522 | Interleukin antagonist | 0.374 0.035 DBMET02912 0.49 0.021 DBMET02914 0.469 0.022 DBMET02915 0.488 0.021 DBMET00476 0.338 0.041 DBMET02913 0.332 0.042 DBMET00353 | ||
| 0.475 | 0.037 | 0.704 | Cholesterol antagonist | 0.594 0.019 DBMET02912 0.324 0.076 DBMET02914 0.532 0.028 DBMET02915 0.333 0.072 DBMET00476 0.704 0.008 DBMET02913 0.558 0.024 DBMET00353 | DBMET02913 | |
| 0.415 | 0.013 | 0.488 | Sodium/bile acid cotransporter inhibitor | 0.431 0.01 DBMET02912 0.387 0.021 DBMET02914 0.42 0.012 DBMET02915 0.425 0.011 DBMET00476 0.477 0.005 DBMET02913 0.488 0.004 DBMET00353 | DBMET00353 | |
| 0.42 | 0.019 | 0.544 | DNA synthesis inhibitor | 0.391 0.023 DBMET02912 0.366 0.027 DBMET02914 0.403 0.021 DBMET02915 0.371 0.026 DBMET00476 0.544 0.01 DBMET02913 0.521 0.012 DBMET00353 | DBMET02913 | |
| 0.382 | 0.008 | 0.432 | Interleukin 6 antagonist | 0.346 0.01 DBMET02912 0.342 0.01 DBMET02914 0.376 0.009 DBMET02915 0.386 0.008 DBMET00476 0.431 0.006 DBMET02913 0.432 0.006 DBMET00353 | DBMET00353 | |
| 0.362 | 0.049 | 0.469 | Spasmolytic | 0.332 0.058 DBMET02912 0.469 0.028 DBMET02914 0.44 0.033 DBMET02915 0.316 0.064 DBMET00476 0.212 0.11 DBMET02913 | DBMET02914 | |
| 0.311 | 0.004 | 0.311 | Mineralocorticoid receptor antagonist | 0.241 0.004 DBMET02912 0.278 0.004 DBMET02914 0.246 0.004 DBMET02915 0.241 0.004 DBMET00476 0.175 0.004 DBMET02913 0.291 0.004 DBMET00353 | ||
| 0.351 | 0.046 | 0.421 | Antioxidant | 0.336 0.05 DBMET02912 0.314 0.057 DBMET02914 0.354 0.045 DBMET02915 0.347 0.047 DBMET00476 0.421 0.031 DBMET02913 0.391 0.036 DBMET00353 | DBMET02913 | |
| 0.337 | 0.041 | 0.381 | Tumour necrosis factor alpha release inhibitor | 0.381 0.03 DBMET02912 0.359 0.036 DBMET02914 0.328 0.044 DBMET02915 0.31 0.049 DBMET00476 0.278 0.062 DBMET02913 0.267 0.067 DBMET00353 | DBMET02912 | |
| 0.311 | 0.027 | 0.524 | P-glycoprotein inhibitor | 0.29 0.031 DBMET02912 0.282 0.033 DBMET02914 0.254 0.04 DBMET02915 0.386 0.018 DBMET00476 0.523 0.007 DBMET02913 0.524 0.007 DBMET00353 | DBMET00353 | |
| 0.328 | 0.056 | 0.337 | Interleukin 2 agonist | 0.337 0.052 DBMET02912 0.244 0.126 DBMET02914 0.335 0.052 DBMET02915 0.27 0.098 DBMET00476 0.335 0.052 DBMET02913 0.323 0.059 DBMET00353 | DBMET02912 | |
| 0.288 | 0.024 | 0.674 | Diuretic | 0.335 0.018 DBMET02912 0.236 0.033 DBMET02914 0.29 0.024 DBMET02915 0.167 0.063 DBMET00476 0.608 0.005 DBMET02913 0.674 0.004 DBMET00353 | DBMET00353 | |
| 0.326 | 0.069 | 0.429 | Apoptosis antagonist | 0.343 0.059 DBMET02912 0.296 0.088 DBMET02914 0.325 0.069 DBMET02915 0.379 0.045 DBMET00476 0.429 0.031 DBMET02913 0.392 0.041 DBMET00353 | DBMET02913 | |
| 0.243 | 0.013 | 0.296 | Farnesoid X receptor antagonist | 0.277 0.008 DBMET02912 0.18 0.029 DBMET02914 0.246 0.012 DBMET02915 0.228 0.015 DBMET00476 0.272 0.009 DBMET02913 0.296 0.006 DBMET00353 | DBMET00353 | |
| 0.244 | 0.015 | 0.244 | Acetylcholine muscarinic antagonist | 0.118 0.069 DBMET02912 0.216 0.021 DBMET02914 0.169 0.034 DBMET02915 0.169 0.034 DBMET00476 | ||
| 0.23 | 0.004 | 0.578 | Aldosterone antagonist | 0.404 0.002 DBMET02912 0.199 0.004 DBMET02914 0.16 0.005 DBMET02915 0.081 0.011 DBMET00476 0.387 0.002 DBMET02913 0.578 0.001 DBMET00353 | DBMET00353 | |
| 0.248 | 0.021 | 0.248 | Cholinergic antagonist | 0.111 0.083 DBMET02912 0.201 0.032 DBMET02914 0.154 0.05 DBMET02915 0.183 0.037 DBMET00476 | ||
| 0.246 | 0.021 | 0.246 | Acetylcholine antagonist | 0.108 0.082 DBMET02912 0.196 0.032 DBMET02914 0.151 0.05 DBMET02915 0.167 0.042 DBMET00476 | ||
| 0.258 | 0.057 | 0.258 | Antimitotic | 0.139 0.134 DBMET02912 0.228 0.069 DBMET02914 0.218 0.075 DBMET02915 0.235 0.066 DBMET00476 | ||
| 0.204 | 0.004 | 0.748 | Anabolic | 0.231 0.002 DBMET02912 0.192 0.005 DBMET02914 0.21 0.003 DBMET02915 0.183 0.006 DBMET00476 0.748 0.001 DBMET02913 0.38 0.001 DBMET00353 | DBMET02913 | |
| 0.25 | 0.05 | 0.554 | Anesthetic general | 0.387 0.018 DBMET02912 0.17 0.094 DBMET02914 0.209 0.07 DBMET02915 0.159 0.105 DBMET00476 0.554 0.005 DBMET02913 0.473 0.01 DBMET00353 | DBMET02913 | |
| 0.23 | 0.031 | 0.513 | NOS3 expression enhancer | 0.274 0.022 DBMET02912 0.132 0.094 DBMET02914 0.237 0.029 DBMET02915 0.161 0.063 DBMET00476 0.427 0.007 DBMET02913 0.513 0.005 DBMET00353 | DBMET00353 | |
| 0.213 | 0.017 | 0.235 | Microtubule formation inhibitor | 0.231 0.014 DBMET02912 0.184 0.024 DBMET02914 0.227 0.014 DBMET02915 0.214 0.017 DBMET00476 0.235 0.013 DBMET02913 0.194 0.021 DBMET00353 | DBMET02913 | |
| 0.199 | 0.005 | 0.821 | Androgen agonist | 0.308 0.003 DBMET02912 0.16 0.007 DBMET02914 0.246 0.004 DBMET02915 0.129 0.009 DBMET00476 0.821 0.001 DBMET02913 0.8 0.001 DBMET00353 | DBMET02913 | |
| 0.23 | 0.05 | 0.331 | Hepatoprotectant | 0.251 0.043 DBMET02912 0.217 0.056 DBMET02914 0.236 0.048 DBMET02915 0.245 0.045 DBMET00476 0.315 0.026 DBMET02913 0.331 0.022 DBMET00353 | DBMET00353 | |
| 0.215 | 0.036 | 0.403 | Lipid peroxidase inhibitor | 0.257 0.025 DBMET02912 0.197 0.043 DBMET02914 0.218 0.035 DBMET02915 0.173 0.054 DBMET00476 0.383 0.01 DBMET02913 0.403 0.009 DBMET00353 | DBMET00353 | |
| 0.184 | 0.005 | 0.551 | Progesterone antagonist | 0.184 0.005 DBMET02912 0.163 0.005 DBMET02914 0.13 0.007 DBMET02915 0.088 0.01 DBMET00476 0.459 0.002 DBMET02913 0.551 0.002 DBMET00353 | DBMET00353 | |
| 0.204 | 0.026 | 0.384 | Cholesterol synthesis inhibitor | 0.281 0.014 DBMET02912 0.116 0.068 DBMET02914 0.225 0.021 DBMET02915 0.143 0.048 DBMET00476 0.384 0.005 DBMET02913 0.321 0.009 DBMET00353 | DBMET02913 | |
| 0.226 | 0.055 | 0.273 | Neurotrophic factor enhancer | 0.273 0.027 DBMET02912 0.178 0.1 DBMET02914 0.197 0.08 DBMET02915 0.213 0.065 DBMET00476 0.269 0.029 DBMET02913 0.258 0.034 DBMET00353 | DBMET02912 | |
| 0.173 | 0.01 | 0.64 | Aromatase inhibitor | 0.361 0.004 DBMET02912 0.142 0.014 DBMET02914 0.146 0.014 DBMET02915 0.174 0.01 DBMET00476 0.624 0.003 DBMET02913 0.64 0.002 DBMET00353 | DBMET00353 | |
| 0.183 | 0.021 | 0.211 | Bronchodilator | 0.1 0.064 DBMET02912 0.19 0.02 DBMET02914 0.211 0.017 DBMET02915 0.176 0.023 DBMET00476 | DBMET02915 | |
| 0.267 | 0.113 | 0.4 | Antithrombotic | 0.23 0.143 DBMET02912 0.287 0.097 DBMET02915 0.236 0.138 DBMET00476 0.4 0.049 DBMET02913 0.259 0.119 DBMET00353 | DBMET02913 | |
| 0.226 | 0.081 | 0.316 | Angiogenesis stimulant | 0.233 0.078 DBMET02912 0.167 0.112 DBMET02914 0.226 0.081 DBMET02915 0.195 0.097 DBMET00476 0.316 0.043 DBMET02913 0.278 0.058 DBMET00353 | DBMET02913 | |
| 0.17 | 0.026 | 0.274 | Antineoplastic antibiotic | 0.135 0.034 DBMET02912 0.18 0.025 DBMET02914 0.159 0.029 DBMET02915 0.196 0.022 DBMET00476 0.243 0.015 DBMET02913 0.274 0.012 DBMET00353 | DBMET00353 | |
| 0.141 | 0.003 | 0.141 | Nitric oxide donor | 0.127 0.004 DBMET02912 0.138 0.003 DBMET02914 0.134 0.003 DBMET02915 0.138 0.003 DBMET00476 0.131 0.003 DBMET02913 0.136 0.003 DBMET00353 | ||
| 0.167 | 0.038 | 0.43 | Alkylator | 0.132 0.057 DBMET02912 0.163 0.04 DBMET02914 0.201 0.026 DBMET02915 0.164 0.04 DBMET00476 0.43 0.006 DBMET02913 0.323 0.011 DBMET00353 | DBMET02913 | |
| 0.148 | 0.024 | 0.301 | Estrogen antagonist | 0.182 0.015 DBMET02912 0.133 0.034 DBMET02914 0.139 0.029 DBMET02915 0.133 0.035 DBMET00476 0.235 0.009 DBMET02913 0.301 0.006 DBMET00353 | DBMET00353 | |
| 0.133 | 0.011 | 0.152 | Na+ K+ transporting ATPase inhibitor | 0.141 0.008 DBMET02912 0.11 0.023 DBMET02914 0.138 0.009 DBMET02915 0.122 0.015 DBMET00476 0.149 0.006 DBMET02913 0.152 0.005 DBMET00353 | DBMET00353 | |
| 0.125 | 0.003 | 0.149 | Progesterone agonist | 0.111 0.003 DBMET02912 0.143 0.003 DBMET02914 0.115 0.003 DBMET02915 0.103 0.003 DBMET00476 0.113 0.003 DBMET02913 0.149 0.003 DBMET00353 | DBMET00353 | |
| 0.162 | 0.044 | 0.338 | Topoisomerase II inhibitor | 0.155 0.047 DBMET02914 0.17 0.041 DBMET02915 0.146 0.052 DBMET00476 0.273 0.021 DBMET02913 0.338 0.014 DBMET00353 | DBMET00353 | |
| 0.141 | 0.03 | 0.223 | Antineoplastic alkaloid | 0.223 0.008 DBMET02912 0.111 0.042 DBMET02914 0.113 0.041 DBMET02915 0.135 0.032 DBMET00476 0.217 0.009 DBMET02913 0.223 0.008 DBMET00353 | DBMET00353 | |
| 0.118 | 0.014 | 0.118 | Acetylcholine M3 receptor antagonist | 0.073 0.03 DBMET02914 0.077 0.027 DBMET02915 0.078 0.027 DBMET00476 | ||
| 0.109 | 0.009 | 0.381 | 5-Alpha-reductase inhibitor | 0.178 0.006 DBMET02912 0.081 0.012 DBMET02914 0.134 0.008 DBMET02915 0.039 0.024 DBMET00476 0.381 0.002 DBMET02913 0.333 0.003 DBMET00353 | DBMET02913 | |
| 0.114 | 0.028 | 0.146 | Transcription factor NF kappa B stimulant | 0.118 0.026 DBMET02912 0.111 0.03 DBMET02914 0.121 0.025 DBMET02915 0.115 0.028 DBMET00476 0.144 0.017 DBMET02913 0.146 0.017 DBMET00353 | DBMET00353 | |
| 0.093 | 0.009 | 0.114 | Heme oxygenase stimulant | 0.1 0.007 DBMET02912 0.088 0.011 DBMET02914 0.093 0.009 DBMET02915 0.087 0.011 DBMET00476 0.098 0.008 DBMET02913 0.114 0.005 DBMET00353 | DBMET00353 | |
| 0.271 | 0.19 | 0.494 | Cyclophilin D inhibitor | 0.494 0.052 DBMET02912 0.339 0.131 DBMET02915 0.238 0.226 DBMET02913 0.311 0.153 DBMET00353 | DBMET02912 | |
| 0.254 | 0.173 | 0.395 | Antibacterial | 0.286 0.146 DBMET02912 0.248 0.179 DBMET02914 0.386 0.083 DBMET02915 0.302 0.134 DBMET00476 0.395 0.079 DBMET02913 0.287 0.145 DBMET00353 | DBMET02913 | |
| 0.082 | 0.008 | 0.171 | RNA-directed RNA polymerase stimulant | 0.096 0.006 DBMET02912 0.034 0.019 DBMET02914 0.081 0.008 DBMET02915 0.05 0.013 DBMET00476 0.127 0.005 DBMET02913 0.171 0.004 DBMET00353 | DBMET00353 | |
| 0.072 | 0.005 | 0.072 | Microtubule stabilization | 0.066 0.009 DBMET02912 0.071 0.006 DBMET02914 0.067 0.008 DBMET02915 0.072 0.005 DBMET00476 0.061 0.014 DBMET02913 0.055 0.021 DBMET00353 | ||
| 0.064 | 0.006 | 0.114 | Glucose-6-phosphate dehydrogenase inhibitor | 0.07 0.005 DBMET02912 0.049 0.012 DBMET02914 0.064 0.006 DBMET02915 0.063 0.006 DBMET00476 0.089 0.003 DBMET02913 0.114 0.003 DBMET00353 | DBMET00353 | |
| 0.117 | 0.06 | 0.223 | DNA intercalator | 0.1 0.073 DBMET02914 0.113 0.062 DBMET02915 0.097 0.077 DBMET00476 0.204 0.025 DBMET02913 0.223 0.02 DBMET00353 | DBMET00353 | |
| 0.077 | 0.024 | 0.262 | Estrogen agonist | 0.101 0.017 DBMET02912 0.082 0.022 DBMET02915 0.055 0.033 DBMET00476 0.191 0.008 DBMET02913 0.262 0.006 DBMET00353 | DBMET00353 | |
| 0.106 | 0.053 | 0.144 | Estrogen receptor beta antagonist | 0.118 0.034 DBMET02912 0.098 0.069 DBMET02915 0.094 0.075 DBMET00476 0.126 0.026 DBMET02913 0.144 0.017 DBMET00353 | DBMET00353 | |
| 0.093 | 0.044 | 0.266 | Topoisomerase II alpha inhibitor | 0.088 0.047 DBMET02914 0.094 0.043 DBMET02915 0.077 0.055 DBMET00476 0.23 0.012 DBMET02913 0.266 0.009 DBMET00353 | DBMET00353 | |
| 0.139 | 0.097 | 0.222 | Melanin inhibitor | 0.191 0.045 DBMET02912 0.144 0.091 DBMET02915 0.222 0.034 DBMET02913 0.176 0.054 DBMET00353 | DBMET02913 | |
| 0.11 | 0.076 | 0.181 | DNA polymerase I inhibitor | 0.133 0.059 DBMET02912 0.112 0.075 DBMET02915 0.181 0.034 DBMET02913 0.161 0.043 DBMET00353 | DBMET02913 | |
| 0.119 | 0.086 | 0.274 | Interleukin 4 antagonist | 0.144 0.055 DBMET02912 0.118 0.089 DBMET02914 0.137 0.064 DBMET02915 0.274 0.01 DBMET02913 0.267 0.011 DBMET00353 | DBMET02913 | |
| 0.101 | 0.068 | 0.168 | Toll-Like receptor 4 antagonist | 0.104 0.063 DBMET02912 0.105 0.061 DBMET02915 0.091 0.088 DBMET00476 0.168 0.013 DBMET02913 0.131 0.034 DBMET00353 | DBMET02913 | |
| 0.049 | 0.018 | 0.13 | Estrogen receptor alpha agonist | 0.075 0.013 DBMET02912 0.043 0.019 DBMET02915 0.09 0.01 DBMET02913 0.13 0.006 DBMET00353 | DBMET00353 | |
| 0.043 | 0.013 | 0.047 | Tubulin agonist | 0.047 0.01 DBMET02912 0.042 0.013 DBMET02914 0.043 0.013 DBMET02915 0.042 0.013 DBMET00476 | DBMET02912 | |
| 0.172 | 0.144 | 0.201 | Peptidyltransferase inhibitor | 0.169 0.148 DBMET02912 0.174 0.139 DBMET02914 0.201 0.097 DBMET02915 0.172 0.144 DBMET00476 0.172 0.142 DBMET00353 | DBMET02915 | |
| 0.031 | 0.009 | 0.143 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.143 0.004 DBMET02912 0.018 0.015 DBMET02914 0.036 0.008 DBMET02915 0.052 0.005 DBMET02913 0.094 0.005 DBMET00353 | DBMET02912 | |
| 0.098 | 0.078 | 0.457 | Monophenol monooxygenase inhibitor | 0.151 0.047 DBMET02912 0.11 0.068 DBMET02915 0.457 0.009 DBMET02913 0.307 0.017 DBMET00353 | DBMET02913 | |
| 0.02 | 0.001 | 0.917 | Transcortin receptor antagonist | 0.038 0.001 DBMET02912 0.008 0.003 DBMET02914 0.02 0.001 DBMET02915 0.012 0.002 DBMET00476 0.348 0 DBMET02913 0.917 0 DBMET00353 | DBMET00353 | |
| 0.128 | 0.11 | 0.221 | Growth hormone agonist | 0.158 0.081 DBMET02912 0.123 0.116 DBMET02914 0.221 0.051 DBMET02913 0.143 0.093 DBMET00353 | DBMET02913 | |
| 0.074 | 0.06 | 0.169 | Estrogen receptor alpha antagonist | 0.111 0.022 DBMET02912 0.132 0.015 DBMET02913 0.169 0.01 DBMET00353 | DBMET00353 | |
| 0.13 | 0.12 | 0.19 | Ca2+-transporting ATPase inhibitor | 0.138 0.079 DBMET02912 0.132 0.11 DBMET02914 0.137 0.085 DBMET02915 0.13 0.12 DBMET00476 0.19 0.004 DBMET02913 0.158 0.026 DBMET00353 | DBMET02913 | |
| 0.025 | 0.015 | 0.026 | Purinergic P2Y12 antagonist | 0.024 0.015 DBMET02914 0.026 0.014 DBMET00476 | DBMET00476 | |
| 0.026 | 0.025 | 0.11 | Estrogen receptor beta agonist | 0.057 0.018 DBMET02912 0.071 0.016 DBMET02913 0.11 0.01 DBMET00353 | DBMET00353 | |
| 0.011 | 0.011 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 DBMET02912 0.012 0.01 DBMET02913 0.014 0.006 DBMET00353 | DBMET00353 | |
| 0.151 | 0.153 | 0.462 | Immunostimulant | 0.221 0.108 DBMET02912 0.18 0.133 DBMET02915 0.462 0.034 DBMET02913 0.344 0.066 DBMET00353 | DBMET02913 | |
| 0.017 | 0.021 | 0.069 | Estrone sulfatase inhibitor | 0.022 0.015 DBMET02912 0.05 0.007 DBMET02913 0.069 0.005 DBMET00353 | DBMET00353 | |
| 0.064 | 0.068 | 0.098 | Glycine receptor agonist | 0.08 0.038 DBMET02912 0.098 0.022 DBMET02913 0.089 0.029 DBMET00353 | DBMET02913 | |
| 0.04 | 0.053 | 0.046 | Protein 50S ribosomal subunit inhibitor | 0.046 0.044 DBMET02915 | DBMET02915 | |
| 0.017 | 0.033 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET00353 | DBMET00353 | |
| 0.066 | 0.083 | 0.141 | Glycine receptor antagonist | 0.087 0.047 DBMET02912 0.141 0.009 DBMET02913 0.111 0.023 DBMET00353 | DBMET02913 | |
| 0.075 | 0.095 | 0.134 | Topoisomerase I inhibitor | 0.097 0.072 DBMET02915 0.134 0.048 DBMET02913 0.134 0.048 DBMET00353 | DBMET00353 | |
| 0.012 | 0.039 | 0.157 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 DBMET02912 0.157 0.004 DBMET02913 0.128 0.004 DBMET00353 | DBMET02913 | |
| 0.01 | 0.05 | 0.019 | Vitamin D receptor agonist | 0.019 0.007 DBMET02913 0.015 0.014 DBMET00353 | DBMET02913 | |
| 0.233 | 0.274 | 0.759 | Caspase 9 stimulant | 0.323 0.169 DBMET02912 0.759 0.017 DBMET02913 0.51 0.056 DBMET00353 | DBMET02913 | |
| 0.071 | 0.116 | 0.091 | T cell inhibitor | 0.091 0.036 DBMET02913 0.091 0.036 DBMET00353 | DBMET00353 | |
| 0.123 | 0.17 | 0.201 | Hypolipemic | 0.149 0.138 DBMET00476 0.201 0.093 DBMET02913 | DBMET02913 | |
| 0.009 | 0.057 | 0.017 | Telomerase stimulant | 0.017 0.013 DBMET00353 | DBMET00353 | |
| 0.007 | 0.057 | 0.118 | 5-Alpha-reductase 1 inhibitor | 0.118 0.004 DBMET02913 0.098 0.005 DBMET00353 | DBMET02913 | |
| 0.067 | 0.128 | 0.084 | ABCA1 expression enhancer | 0.084 0.078 DBMET02912 | DBMET02912 | |
| 0.064 | 0.132 | 0.077 | Thioredoxin reductase inhibitor | 0.077 0.071 DBMET02913 | DBMET02913 | |
| 0.102 | 0.173 | 0.189 | Adenylate cyclase stimulant | 0.154 0.057 DBMET02912 0.124 0.115 DBMET02915 0.189 0.019 DBMET02913 0.166 0.04 DBMET00353 | DBMET02913 | |
| 0.047 | 0.125 | 0.069 | CDC25A inhibitor | 0.069 0.058 DBMET02913 | DBMET02913 | |
| 0.03 | 0.111 | 0.075 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.042 DBMET02912 0.075 0.019 DBMET00353 | DBMET00353 | |
| 0.058 | 0.141 | 0.145 | Expectorant | 0.145 0.037 DBMET02913 0.107 0.061 DBMET00353 | DBMET02913 | |
| 0.115 | 0.199 | 0.253 | Free radical scavenger | 0.253 0.067 DBMET02913 0.158 0.136 DBMET00353 | DBMET02913 | |
| 0.106 | 0.196 | 0.611 | Aldehyde oxidase inhibitor | 0.246 0.084 DBMET02912 0.485 0.035 DBMET02913 0.611 0.017 DBMET00353 | DBMET00353 | |
| 0.078 | 0.171 | 0.3 | Interleukin 8 antagonist | 0.117 0.066 DBMET02912 0.248 0.006 DBMET02913 0.3 0.004 DBMET00353 | DBMET00353 | |
| 0.033 | 0.127 | 0.054 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.046 DBMET02913 | DBMET02913 | |
| 0.008 | 0.108 | 0.054 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.037 0.013 DBMET02913 0.054 0.008 DBMET00353 | DBMET00353 | |
| 0.017 | 0.123 | 0.039 | Hedgehog signaling activator | 0.039 0.005 DBMET02913 0.037 0.005 DBMET00353 | DBMET02913 | |
| 0.081 | 0.19 | 0.135 | Neurotrophic factor | 0.135 0.075 DBMET02912 0.13 0.081 DBMET02913 0.117 0.1 DBMET00353 | DBMET02912 | |
| 0.045 | 0.155 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET02912 | DBMET02912 | |
| 0.061 | 0.173 | 0.132 | Mucolytic | 0.132 0.044 DBMET02913 0.106 0.07 DBMET00353 | DBMET02913 | |
| 0.056 | 0.173 | 0.111 | Bile acid receptor antagonist | 0.09 0.075 DBMET02912 0.111 0.03 DBMET02913 0.109 0.032 DBMET00353 | DBMET02913 | |
| 0.059 | 0.18 | 0.134 | Beta glucuronidase inhibitor | 0.104 0.064 DBMET02912 0.134 0.034 DBMET00353 | DBMET00353 | |
| 0.054 | 0.184 | 0.111 | Thioredoxin inhibitor | 0.111 0.038 DBMET02913 | DBMET02913 | |
| 0.009 | 0.149 | 0.05 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.05 0.011 DBMET00353 | DBMET00353 | |
| 0.056 | 0.203 | 0.137 | Bone formation stimulant | 0.137 0.07 DBMET02913 0.117 0.088 DBMET00353 | DBMET02913 | |
| 0.057 | 0.213 | 0.079 | Estrogen-related receptor beta agonist | 0.079 0.07 DBMET00353 | DBMET00353 | |
| 0.08 | 0.236 | 0.16 | Platelet adhesion inhibitor | 0.16 0.095 DBMET02913 | DBMET02913 | |
| 0.105 | 0.264 | 0.41 | DNA damaging | 0.191 0.123 DBMET02912 0.41 0.026 DBMET02913 0.309 0.054 DBMET00353 | DBMET02913 | |
| 0.067 | 0.232 | 0.251 | Protein kinase stimulant | 0.115 0.098 DBMET02912 0.109 0.105 DBMET02914 0.251 0.026 DBMET02913 0.115 0.098 DBMET00353 | DBMET02913 | |
| 0.096 | 0.273 | 0.258 | Phospholipase C inhibitor | 0.258 0.023 DBMET02913 0.161 0.086 DBMET00353 | DBMET02913 | |
| 0.009 | 0.187 | 0.101 | Estradiol 17 beta-dehydrogenase inhibitor | 0.042 0.029 DBMET02913 0.101 0.01 DBMET00353 | DBMET00353 | |
| 0.049 | 0.266 | 0.127 | Nav1.1 sodium channel blocker | 0.127 0.044 DBMET02912 | DBMET02912 | |
| 0.091 | 0.311 | 0.211 | Hypoglycemic | 0.211 0.102 DBMET02915 | DBMET02915 | |
| 0.026 | 0.253 | 0.058 | Pregnane X receptor antagonist | 0.058 0.036 DBMET02913 0.057 0.038 DBMET00353 | DBMET02913 | |
| 0.043 | 0.286 | 0.148 | Adenylate cyclase inhibitor | 0.145 0.048 DBMET02913 0.148 0.046 DBMET00353 | DBMET00353 | |
| 0.118 | 0.375 | 0.321 | Caspase 3 stimulant | 0.319 0.07 DBMET02913 0.321 0.069 DBMET00353 | DBMET00353 | |
| 0.023 | 0.29 | 0.099 | Inducible nitric-oxide synthase inhibitor | 0.083 0.057 DBMET02913 0.099 0.038 DBMET00353 | DBMET00353 | |
| 0.058 | 0.326 | 0.202 | Interleukin agonist | 0.202 0.119 DBMET02913 | DBMET02913 | |
| 0.044 | 0.332 | 0.101 | Photosensitizer | 0.101 0.087 DBMET02913 | DBMET02913 | |
| 0.03 | 0.318 | 0.077 | Keratolytic | 0.077 0.053 DBMET00353 | DBMET00353 | |
| 0.089 | 0.393 | 0.214 | Immunomodulator | 0.214 0.147 DBMET02913 | DBMET02913 | |
| 0.081 | 0.41 | 0.299 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.293 0.026 DBMET02913 0.299 0.024 DBMET00353 | DBMET00353 | |
| 0.029 | 0.371 | 0.126 | Thrombolytic | 0.126 0.103 DBMET02913 | DBMET02913 | |
| 0.034 | 0.429 | 0.118 | Vanilloid agonist | 0.118 0.019 DBMET02912 | DBMET02912 | |
| 0.041 | 0.471 | 0.128 | Pregnane X receptor agonist | 0.128 0.104 DBMET00353 | DBMET00353 | |
| 0.021 | 0.459 | 0.11 | AMP-activated protein kinase stimulant | 0.104 0.065 DBMET02913 0.11 0.058 DBMET00353 | DBMET00353 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |